Search for: "Novartis Corporation " Results 61 - 80 of 312
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
14 Jan 2018, 4:00 am
Novartis Pharmaceuticals Corporation, S233898).Le producteur d'un carburant vendu en gros n'est redevable d'aucun devoir d'aviser des risques envers le consommateur final, lorsque le producteur a donné un avis adéquat au distributeur, auquel revient les tâches de conditionner et d'écouler le produit. [read post]
13 Jan 2018, 8:00 pm
Novartis suggests that we recently conflated strict liability and negligence in Webb v. [read post]
21 Nov 2017, 2:40 pm by Tom Lamb
We recommend that the FDA and [Novartis Pharmaceuticals Corporation] the manufacturer [of Entresto] more clearly communicate the full risk of hypotension, including appropriate steps for monitoring patients, and examine whether a more gradual escalation of dose to the recommended level would reduce the risk. [read post]
5 May 2017, 9:12 am by Dennis Crouch
  (Even a Federal Circuit panel endorsed the latter as recently as a month ago in Novartis AG v. [read post]
16 Sep 2016, 4:07 am by John Collins
John Collins and Sumer DayalClayton Utz On 9 September 2016, the Full Federal Court of Australia delivered its judgment in Actavis Pty Ltd v Orion Corporation [2016] FCAFC 121 (Actavis). [read post]
2 Jun 2016, 5:23 am by Mary Jane Wilmoth
.; Medical Capital Corporation; Medical Provider Funding Corporation VI; Sidney M. [read post]
29 Jan 2016, 3:58 am by SHG
Now that was a crime worthy of redress, but it’s hard to blame Novartis for doing what was in its corporate interests. [read post]
2 Nov 2015, 2:05 pm by Michael Rosenblat
  (See, Blog post DOJ to Focus on Individual Accountability for Corporate Fraud.) [read post]
11 Oct 2015, 6:56 am by INFORRM
A final order could be obtained against such a defendant, as had occurred in Novartis Pharmaceuticals UK Ltd v Stop Huntingdon Animal Cruelty & Ors [2014] EWHC 3429 (QB). [read post]
15 Sep 2015, 2:20 pm by Tom Lamb
This September 2015 Drug Safety Alert Is Based Primarily On Reports Of Skin Cancer And Lymphoma Blood Cancer &nbsp (Posted by Tom Lamb at DrugInjuryWatch.com)   Health Canada recently conducted a review of safety information obtained from the drug company Novartis Pharmaceuticals Corporation, the manufacturer of Gilenya (fingolimod), about a potential link between the use of this multiple sclerosis (MS) drug and certain types of cancers and malignant tumors or neoplasms. [read post]